CDKs: Taking on a role as mediators of dopaminergic loss in Parkinson's disease

Trends in Molecular Medicine

Volumn 10, Issue 9, 2004, Pages 445-451

  Smith, Patrice D ^a   O'Hare, Michael J ^a   Park, David S ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ISOENZYME;

BRAIN NERVE CELL; CELL DEATH; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; HUMAN; MITOSIS; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PATHOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CYCLIN-DEPENDENT KINASES; DOPAMINE; HUMANS; MITOSIS; NEURONS; PARKINSON DISEASE;

EID: 4444285321     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.07.003     Document Type: Review

References (70)

1. J.A. Obeso Pathophysiology of the basal ganglia in Parkinson's disease Trends Neurosci. 23 2000 S8 19
2. W. Dauer, and S. Przedborski Parkinson's disease: mechanisms and models Neuron 39 2003 889 909
3. N. Hattori Familial Parkinson's disease: a hint to elucidate the mechanisms of nigral degeneration J. Neurol. 250 Suppl. 3 2003 III2 II10
4. K. Chergui Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum Proc. Natl. Acad. Sci. U. S. A. 101 2004 2191 2196
5. J.D. Oh, and T.N. Chase Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease Amino Acids 23 2002 133 139
6. P.D. Smith Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 13650 13655
7. A.W. Murray Recycling the cell cycle: cyclins revisited Cell 116 2004 221 234
8. O. Stevaux, and N.J. Dyson A revised picture of the E2F transcriptional network and RB function Curr. Opin. Cell Biol. 14 2002 684 691
9. L.A. Porter, and D.J. Donoghue Cyclin B1 and CDK1: nuclear localization and upstream regulators Prog. Cell Cycle Res. 5 2003 335 347
10. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
11. K. Vermeulen The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer Cell Prolif. 36 2003 131 149
12. A. Copani Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path? Trends Neurosci. 24 2001 25 31
13. D.S. Park Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents J. Cell Biol. 143 1998 457 467
14. A. Giovanni Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death J. Biol. Chem. 274 1999 19011 19016
15. J. Katchanov Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death J. Neurosci. 21 2001 5045 5053
16. D.S. Park Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons J. Neurosci. 17 1997 8975 8983
17. D.S. Park Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage J. Neurosci. 20 2000 3104 3114
18. A. Giovanni E2F1 mediates death of β-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3 J. Biol. Chem. 275 2000 11553 11560
19. M.J. O'Hare Induction and modulation of cerebellar granule neuron death by E2F-1 J. Biol. Chem. 275 2000 25358 25364
20. A. Copani Mitotic signaling by β-amyloid causes neuronal death FASEB J. 13 1999 2225 2234
21. H.J. Rideout Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition J. Neurosci. 23 2003 1237 1245
22. Y. Konishi Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery Mol. Cell 9 2002 1005 1016
23. R.M. Feddersen Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice Neuron 9 1992 955 966
24. R.M. Feddersen In vivo viability of postmitotic Purkinje neurons requires pRb family member function Mol. Cell. Neurosci. 6 1995 153 167
25. F. Zindy Postnatal neuronal proliferation in mice lacking Ink4d and Kip1 inhibitors of cyclin-dependent kinases Proc. Natl. Acad. Sci. U. S. A. 96 1999 13462 13467
26. H. Osuga Cyclin-dependent kinases as a therapeutic target for stroke Proc. Natl. Acad. Sci. U. S. A. 97 2000 10254 10259
27. M.D. Nguyen Cell cycle regulators in the neuronal death pathway of amyotrophic lateral sclerosis caused by mutant superoxide dismutase 1 J. Neurosci. 23 2003 2131 2140
28. J. Busser Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain J. Neurosci. 18 1998 2801 2807
29. J.W. Husseman Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases Neurobiol. Aging 21 2000 815 828
30. A. Copani Erratic expression of DNA polymerases by β-amyloid causes neuronal death FASEB J. 16 2002 2006 2008
31. Q. Wu β-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons Neurobiol. Aging 21 2000 797 806
32. Y. Yang DNA replication precedes neuronal cell death in Alzheimer's disease J. Neurosci. 21 2001 2661 2668
33. J.F. Staropoli Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity Neuron 37 2003 735 749
34. K.L. Jordan-Sciutto Expression patterns of retinoblastoma protein in Parkinson disease J. Neuropathol. Exp. Neurol. 62 2003 68 74
35. T. Ohshima Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death Proc. Natl. Acad. Sci. U. S. A. 93 1996 11173 11178
36. T. Rashid Phosphorylation of Pak1 by the p35/Cdk5 kinase affects neuronal morphology J. Biol. Chem. 276 2001 49043 49052
37. T. Chae Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality Neuron 18 1997 29 42
38. Y.T. Kwon Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase Curr. Biol. 10 2000 363 372
39. J.P. Julien, and W.E. Mushynski Neurofilaments in health and disease Prog. Nucleic Acid Res. Mol. Biol. 61 1998 1 23
40. nck5a interaction with synaptic proteins in bovine brain J. Cell. Biochem. 78 2000 151 159
41. J.A. Bibb Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons Nature 402 1999 669 671
42. L.H. Tsai p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 Nature 371 1994 419 423
43. D. Tang An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator J. Biol. Chem. 270 1995 26897 26903
44. L.R. Zukerberg Cables links Cdk5 and c-Abl and facilitates Cdk5 tyrosine phosphorylation, kinase upregulation, and neurite outgrowth Neuron 26 2000 633 646
45. J. Rosales Cdk7 functions as a cdk5 activating kinase in brain Cell. Physiol. Biochem. 13 2003 285 296
46. nck5a complex Mol. Cell 8 2001 657 669
47. G.N. Patrick Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration Nature 402 1999 615 622
48. M.S. Lee Neurotoxicity induces cleavage of p35 to p25 by calpain Nature 405 2000 360 364
49. A. Alvarez Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death FEBS Lett. 459 1999 421 426
50. X. Gong Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis Neuron 38 2003 33 46
51. M.D. Nguyen Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions Neuron 30 2001 135 147
52. B. Bu Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model J. Neurosci. 22 2002 6515 6525
53. K.C. Nguyen Controversies over p25 in Alzheimer's disease J. Alzheimers Dis. 4 2002 123 126
54. J.C. Cruz Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles Neuron 40 2003 471 483
55. J. Wang Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors Nat. Neurosci. 6 2003 1039 1047
56. J. Zhang Cdk5 phosphorylates p53 and regulates its activity J. Neurochem. 81 2002 307 313
57. P.A. Trimmer Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity Neurodegeneration 5 1996 233 239
58. B.S. Li Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3 EMBO J. 21 2002 324 333
59. J.P. Brion, and A.M. Couck Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5 Am. J. Pathol. 147 1995 1465 1476
60. nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease Acta Neuropathol. (Berl.) 94 1997 153 157
61. C. Henchcliffe, and R.E. Burke Increased expression of cyclin-dependent kinase 5 in induced apoptotic neuron death in rat substantia nigra Neurosci. Lett. 230 1997 41 44
62. M. Neystat Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo J. Neurochem. 77 2001 1611 1625
63. B.F. El-Khodor Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta Exp. Neurol. 179 2003 17 27
64. J.L. Tseng GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine J. Neurosci. 17 1997 325 333
65. T.J. Collier Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease J. Comp. Neurol. 442 2002 320 330
66. S.J. Crocker c-Jun mediates axotomy-induced dopamine neuron death in vivo Proc. Natl. Acad. Sci. U. S. A. 98 2001 13385 13390
67. S.J. Crocker Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease J. Neurosci. 23 2003 4081 4091
68. K.Y. Lee Neuronal Cdc2-like kinase (Nclk) binds and phosphorylates the retinoblastoma protein J. Biol. Chem. 272 1997 5622 5626
69. M.A. Lazzaro A novel cdc2-related protein kinase expressed in the nervous system J. Neurochem. 69 1997 348 364
70. J.M. Lahti PITSLRE protein kinase activity is associated with apoptosis Mol. Cell. Biol. 15 1995 1 11